Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose

Pharmacological Research

Volumn 55, Issue 1, 2007, Pages 38-41

  Pea, Federico ^a   Marioni, Gino ^b   Pavan, Federica ^a   Staffieri, Claudia ^b   Bottin, Raffaele ^b   Staffieri, Alberto ^b   Furlanut, Mario ^a  

^a University Medical School   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Levofloxacin; Pharmacokinetics; Sinusal mucosa

Indexed keywords

LEVOFLOXACIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; NOSE MUCOSA; PARANASAL SINUS; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; SINGLE DRUG DOSE; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; OFLOXACIN; PARANASAL SINUSES; RHINITIS; SINUSITIS;

EID: 33846217028     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.10.003     Document Type: Article

References (20)

1. Anon, Jacobs M.R., Poole M.D., Ambrose P.G., Benninger M.S., Hadley J.A., et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 130 (2004) 1-45
2. Gwaltney Jr. J.M., Sydnor Jr. A., and Sande M.A. Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol Suppl 90 (1981) 68-71
3. Poole M.D., and Portugal L.G. Treatment of rhinosinusitis in the outpatient setting. Am J Med 118 Suppl. 7A (2005) 45S-50S
4. Klossek J.M., and Federspil P. Update on treatment guidelines for acute bacterial sinusitis. Int J Clin Pract 59 (2005) 230-238
5. Adelglass J., Jones T.M., Ruoff G., Kahn J.B., Wiesinger B.A., Rielly-Gauvin K., et al. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 18 (1998) 1255-1263
6. Lasko B., Lau C.Y., Saint-Pierre C., Reddington J.L., Martel A., and Anstey R.J. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. J Int Med Res 26 (1998) 281-291
7. Sydnor T.A., Kopp E.J., Anthony K.E., LoCoco J.M., Kim S.S., and Fowler C.L. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. Ann Allergy Asthma Immunol 80 (1998) 357-362
8. Adelglass J., DeAbate C.A., McElvaine P., Fowler C.L., LoCocco J., and Campbell T. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngol Head Neck Surg 120 (1999) 320-327
9. Chiu A.G., and Kennedy D.W. Surgical management of chronic rhinosinusitis and nasal polyposis: a review of the evidence. Curr Allergy Asthma Rep 4 (2004) 486-489
10. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
11. Pea F., Di Qual E., Cusenza A., Brollo L., Baldassarre M., and Furlanut M. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia. Clin Pharmacokinet 42 (2003) 589-598
12. Murphy D.B., Sutton J.A., Prescott L.F., and Murphy M.B. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 87 (1997) 765-770
13. Wallden J., Thorn S.E., and Wattwil M. The delay of gastric emptying induced by remifentanil is not influenced by posture. Anesth Analg 99 (2004) 429-434 [table of contents]
14. Gehanno P., Darantiere S., Dubreuil C., Chobaut J.C., Bobin S., Pages J.C., et al. A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus. J Antimicrob Chemother 49 (2002) 821-826
15. Preston S.L., Drusano G.L., Berman A.L., Fowler C.L., Chow A.T., Dornseif B., et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279 (1998) 125-129
16. Aminimanizani A., Beringer P., and Jelliffe R. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials. Clin Pharmacokinet 40 (2001) 169-187
17. Hurst M., Lamb H.M., Scott L.J., and Figgitt D.P. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs 62 (2002) 2127-2167
18. Dinis P.B., Monteiro M.C., Martins M.L., Silva N., and Morais J.G. Sinus tissue concentration of moxifloxacin after a single oral dose. Ann Otol Rhinol Laryngol 113 (2004) 142-146
19. Tolsdorff P. Penetration of ofloxacin into nasal tissues. Infection 21 (1993) 66-70
20. Gesu G.P., Marchetti F., Piccoli L., and Cavallero A. Levofloxacin and ciprofloxacin in vitro activities against 4003 clinical bacterial isolates collected in 24 Italian laboratories. Antimicrob Agents Chemother 47 (2003) 816-819